DNA labeling in vivo using nucleoside analogues is a current experimental approach to determine cell proliferation rates in cell cultures and tissues. It has also been successfully used to localize adult stem cell niches through the identification of nucleoside label retaining cells (LRC) in long term experiments. A major hindrance of this methodology relies on the selection of adequate procedures to quantify the nucleoside analogue content from image data files. Here we propose a simple procedure using Fiji image processing software to accurately calculate nucleoside analogue retaining chromatin/total chromatin (LRC/DAPI) signal ratios in the wellknown mouse hair follicle stem cell niche.
Introduction
Metabolic labeling of the DNA molecule in vivo is a powerful methodology to study cell proliferation and differentiation dynamics in culture cells and whole tissues or organisms (1). The basis of this methodology is the addition of chemically modified 3 nucleoside analogues to target samples. After a short labeling pulse, passive or active cellular uptake mechanisms and subsequent nuclear translocation result in the accumulation of phosphorylated modified nucleosides in the nuclear compartment, where they are incorporated into the DNA molecule mainly through successive rounds of conservative replication (Fig. 1A) . Cells showing high DNA replication rates are thus expected to show a faster and greater accumulation of modified nucleosides.
Interestingly, an immediate and fruitful application of DNA labeling in living cells and tissues has been the identification of putative stem cell niches in adult eukaryotic organisms (2-9). Delivering huge nucleoside analogue amounts in vivo through consecutive labeling pulses results in a widespread nuclear accumulation and subsequent massive incorporation of these compounds into the DNA molecule through different mechanisms, including DNA replication, excision repair mechanisms and reverse transcription in retrotransposon genomic regions. This process ultimately results in a homogenous modified nucleoside labeling of most nuclei in the target organism (Fig. 1B) . A defining hallmark of mammalian adult stem cells, along with the capacity of differentiation in one or more different cell types and the potential to selfrenew, is the active maintenance of a quiescent, low-proliferating state. In this context, an extensive and homogenous DNA nucleoside analogue label is expected to be progressively lost in a long term time period in most proliferating cells in a tissue after successive DNA replication rounds, but retained in the quiescent, reported adult stem cell population (Fig. 1C) . The existence of this Label Retaining Cells (LRC) population has been nicely demonstrated in the mouse hair follicle stem cell niche model and this experimental approach has enormously contributed to our knowledge on adult stem cell biology (4, 9).
Historically, metabolic DNA labeling has been performed by using thymidine derivatives including tritiated thymidine (10) or halogenated analogues like bromo-deoxyuridine (BrdU), chloro-deoxyuridine (CldU) or iodo-deoxyuridine (IdU) (11-14). Detection of 4 incorporated marks is subsequently performed by autoradiography, in the case of radioactive derivatives, or by using specific antibodies, in the case of halogenated nucleosides. Due to its radioactive nature, tritiated thymidine is at present virtually out of experimental use. For its part, major drawbacks of experimental protocols using halogenated nucleosides are the requirement of specific treatments to unmask analogue epitopes on fixed chromatin, typically by mild acid hydrolysis or nuclease digestion, and the overall constraining of detection efficiency by the permeability of target samples to antibody diffusion (11-14). As an additional hindrance, some degree of cell and tissue toxicity, including mutagenic and teratogenic effects (15-20), has also been reported for both radioactive or halogenated nucleoside analogues.
In the last decade, bioorthogonal chemical reporter approaches 
Materials

2.
1. BrdU DNA labelling in new born mice.
1. Ten-day-old C57BL/6j mouse pups.
2. Distilled water.
3. PBS, 5mM EDTA in PBS, 0.02 % sodium azide in PBS.
1N HCl (Merck).
5. Tris-borate-EDTA (TBE) buffer.
6. 5-bromo-2'-deoxyuridine (BrdU; Sigma) (see Note 1).
7. 12-O-tetradecanoil-phorbol-13-acetate (TPA; Sigma). Prepare a 20 nM stock in acetone and store at -20 ºC. 12. Insulin type syringes, needles, sterile surgical scalpel blades, scissors and tweezers. 13 . Heater (at 37 ºC).
Confocal microscopy and image processing software (see Note 5).
1. Leica TCS SP2 or SP5 AOBS Laser Scanning Spectral Confocal Microscopes. 1. Inject ten-day-old mice intraperitoneally (i.p.) once a day during 4 consecutive days with 12 mg/ml BrdU in PBS (50 mg/kg body weight) (see Note 6).
2. Let the mice grow for a minimum of 50 days in standard housing conditions. 1. Sacrifice the mice following the guidelines of the corresponding housing animal facility, cut the tail and peel the skin in a whole piece from the tail backbone.
2. Incubate the peeled tail skin in PBS with 5 mM EDTA at 37 ºC for 4 h.
3. Separate the epidermis from the dermis using tweezers and fix the intact sheet of epidermal tissue with 3.7 % formaldehyde in PBS at 4 ºC for at least 72 h. 
Image capture and digital quantification of BrdU LRC area fraction with
respect to total chromatin area fraction in the hair follicle (see Fig. 2 ).
1. Use the image acquisition software coupled to the confocal microscopy device to obtain stacks of images of LRC-FITC or DAPI distribution covering the whole thickness of the hair follicles between selected boundaries. Obtain the maximum projection of each image stack and save as a single snapshot. 
